Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT05632068
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT05632068
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT05632068. Randomized; no masking; primary purpose treatment. Start 2022-12-13 (actual); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity
- Condition
- Hyperlipidemias
- Condition
- Obesity
- Condition
- Body Fat Disorder
- Intervention (Drug)
- Xian-Hua-Cha
- Lead sponsor
- Chang Gung Memorial Hospital
Record details
- Record id
cardio:ct-nct05632068- Content hash
8fe4e7cb76f0a4bc993b7f6ddeecac5c784347bb97ac471faf2c8af3a6493248